Searched for
PHARMA EXPORT SALES
Healthium Medtech CEO Anish Bafna steps down, moves to non-executive chairman roleHealthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...- PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stakePrivate equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...
- June quarter earnings to determine market direction, says Sunil Subramaniam, warns on risks in near termMarket expert Sunil Subramaniam advised caution amid geopolitical uncertainty and rising input costs, while favouring consumer durables, ca...
- Eicher Motors Q4 Results: Cons profit grows 12% YoY to Rs 1,520 crore, revenue jumps 16%Eicher Motors, the maker of Royal Enfield, posted a 12% rise in net profit for the March quarter of FY26. The company's revenue also saw a ...
- HAB Pharma merges Signature Phytochemicals, eyes Rs3,000 crore revenue by 2030HAB Pharma and Signature Phytochemicals have merged, creating a consolidated entity with a turnover of Rs600 crore. This strategic move aim...
- Specialty chemicals: Is China still the same threat, or is this a contrarian moment? 7 stocks to be brought back on the watchlistWhen it comes to the Indian speciality chemicals sector, China and its dumping matters. But there have been subtle but significant changes ...
- Earnings season is strong, but Q1 pain is coming: Dipan MehtaMarket expert Dipan Mehta finds India's current earnings season strong. He notes that future quarters will test corporate India due to pote...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%We are living in times when the morning may see conciliatory exchanges between the US and Iran, leading to a cooling in crude oil prices. B...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- For investors with long-term perspective: 5 mid-cap stocks from different sectors with upside potential of up to 30%Even before the US-Israel-Iran war began, there was a sort of readjustment taking place in the mid-cap segment – a kind of valuation readju...
- Govt's ammonia rule to hurt pharma cos as directive restricts sale of surplus to fertiliser firmsIndia’s pharmaceutical industry faces a potential raw material crunch after the government restricted surplus ammonia supply to fertiliser ...
- Bain Capital sole contender for Vitabiotics buyBain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...
- India's pharma export sales to grow faster this yearIndia's pharmaceutical exports are projected to grow nearly 11% this fiscal year, up from about 10% last year, driven by the U.S. and UK ma...
- Rally in pharma stocks lifts benchmark indicesLong-term structural growth potential driven by anticipated shortage and price increases prompted investors to shuffle their bets in favour...
- Weak rupee to boost earnings of pharma exporters like Sun Pharma, Cipla, Dr Reddy's Labs, Cadila HealthcareHigher export realisations would help to enhance the overall performance of many companies in the sector for the current September quarter.
- Gujarat-based pharma firms in pink of healthWhen major companies are facing pressure on their balancesheets, Gujarat-based pharmaceutical firm have registered a healthy growth and see...
- Dip in US drug sales may hit Indian cosPharma industry tracking body, the US-based IMS Health, has highlighted that pharma sales in the US are likely to decline by 1-2% y-o-y thi...
- Pharma exports to surpass retail salesBy 2012, exports will double at Rs 112,275 cr growing at 35% against domestic sales of Rs 58,607 cr.
- Sun Pharma Q4 net up 38% to Rs143 croreBuoyed by higher exports, domestic pharmaceutical player, Sun Pharma, has posted a net profit of Rs 142.9 crore for the fourth quarter ende...
Load More
